Article
An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk.
Cancer research - 1 Dec 2012
Zhu Zhansheng, Gao Xueren, He Yan, Zhao Hua, Yu Qiang, Jiang Deke, Zhang Pingzhao, Ma Xiaopin, Huang Huixing, Dong Dong, Wan Jiao, Gu Zhenyong, Jiang Xinghong, Yu Long, Gao Yuzhen
Abstract excerpt
The Prolyl hydroxylase 1 (EGLN2) is known to affect tumorigenesis by regulating the degradation of hypoxia-inducible factor. Polymorphisms in EGLN2 may facilitate cancer cell survival under hypoxic conditions and directly associate with cancer susceptibility. Here, we examined the contribution of a 4-bp insertion/deletion polymorphism (rs10680577) within the distal promoter of EGLN2 to the risk of hepatocelluar...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
